Wouter V Vogel
Overview
Explore the profile of Wouter V Vogel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vogel W, Steemers-de Boer M, Jansen S, Rijkhorst E, de Wit-van der Veen B, van der Hiel B, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 40014073
No abstract available.
2.
Wagenaar D, Mohan V, Langendijk J, Steenbakkers R, Vogel W, Both S
Clin Transl Radiat Oncol
. 2025 Feb;
52:100910.
PMID: 39925864
Background And Purpose: A recent study investigated the use of PSMA-PET in monitoring loss of secretory cells in salivary glands of head and neck cancer (HNC) patients. Previously, a dose-effect...
3.
Willemse J, Lahaye M, Goedegebuure E, Snaebjornsson P, Marchetti S, Vollebergh M, et al.
Eur Radiol
. 2024 Oct;
PMID: 39470795
Purpose: This study aimed to evaluate the added benefit of body MRI (covering the chest, abdomen, and pelvis) to detect the primary tumour in patients with adenocarcinoma of unknown primary...
4.
Willemse J, Lambregts D, Balduzzi S, Schats W, Snaebjornsson P, Marchetti S, et al.
Eur J Nucl Med Mol Imaging
. 2024 Aug;
52(1):225-236.
PMID: 39141069
Purpose: In this systematic review and individual patient data (IPD) meta-analysis, we analysed the diagnostic performance of [F]FDG PET/CT in detecting primary tumours in patients with CUP and evaluated whether...
5.
Navran A, Kayembe M, Gouw Z, Vogel W, Karssemakers L, de Boer J, et al.
Radiother Oncol
. 2024 Jun;
198:110407.
PMID: 38942119
Purpose: In the last decades FDG-PET/CT is increasingly used in combination with the standard diagnostic modalities (MRI + US-FNA) to identify residual neck disease (RND) after (chemo)radiotherapy for head-and-neck squamous...
6.
Siebinga H, de Wit-van der Veen B, de Vries-Huizing D, Vogel W, Hendrikx J, Huitema A
EJNMMI Phys
. 2024 Apr;
11(1):39.
PMID: 38656678
Background: There is an unmet need for prediction of treatment outcome or patient selection for [Lu]Lu-PSMA therapy in patients with metastatic castration-resistant prostate cancer (mCRPC). Quantification of the tumor exposure-response...
7.
Al-Mamgani A, Kessels R, Gouw Z, Navran A, Mohan V, Van de Kamer J, et al.
Clin Transl Radiat Oncol
. 2023 Sep;
43:100676.
PMID: 37753461
Purpose: To report on the late toxicity and local control (LC) of head and neck cancer patients treated with adaptive FDG-PET/CT response-guided radiotherapy (ADMIRE) with dose escalation (NCT03376386). Materials And...
8.
Zuur L, de Barros H, van der Mijn K, Vis A, Bergman A, Pos F, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296924
There is currently no consensus on the optimal treatment for patients with a primary diagnosis of clinically and pathologically node-positive (cN1M0 and pN1M0) hormone-sensitive prostate cancer (PCa). The treatment paradigm...
9.
van der Sar E, Braat A, van der Voort-van Zyp J, van der Veen B, van Leeuwen P, de Vries-Huizing D, et al.
BMC Cancer
. 2023 Mar;
23(1):268.
PMID: 36959540
Background: Prostate cancer patients with locoregional lymph node disease at diagnosis (N1M0) still have a limited prognosis despite the improvements provided by aggressive curative intent multimodal locoregional external beam radiation...
10.
de Barros H, Duin J, Mulder D, van der Noort V, Noordzij M, Wit E, et al.
Eur Urol Open Sci
. 2023 Mar;
49:80-89.
PMID: 36874598
Background: Accurate identification of men who harbor nodal metastases is necessary to select patients who most likely benefit from whole pelvis radiotherapy (WPRT). Limited sensitivity of diagnostic imaging approaches for...